BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 23269521)

  • 1. Impaired mitochondrial metabolism and mammary carcinogenesis.
    Yadava N; Schneider SS; Jerry DJ; Kim C
    J Mammary Gland Biol Neoplasia; 2013 Mar; 18(1):75-87. PubMed ID: 23269521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Environmental exposures, breast development and cancer risk: Through the looking glass of breast cancer prevention.
    Forman MR; Winn DM; Collman GW; Rizzo J; Birnbaum LS
    Reprod Toxicol; 2015 Jul; 54():6-10. PubMed ID: 25499721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A special issue dedicated to a complex tissue.
    Fenton SE
    Reprod Toxicol; 2015 Jul; 54():1-5. PubMed ID: 25986312
    [No Abstract]   [Full Text] [Related]  

  • 4. Evaluating chemical effects on mammary gland development: A critical need in disease prevention.
    Osborne G; Rudel R; Schwarzman M
    Reprod Toxicol; 2015 Jul; 54():148-55. PubMed ID: 25091782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advancing research on endocrine disrupting chemicals in breast cancer: Expert panel recommendations.
    Teitelbaum SL; Belpoggi F; Reinlib L
    Reprod Toxicol; 2015 Jul; 54():141-7. PubMed ID: 25549947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metals and breast cancer.
    Byrne C; Divekar SD; Storchan GB; Parodi DA; Martin MB
    J Mammary Gland Biol Neoplasia; 2013 Mar; 18(1):63-73. PubMed ID: 23338949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Putative role of adipose tissue in growth and metabolism of colon cancer cells.
    Schwartz B; Yehuda-Shnaidman E
    Front Oncol; 2014; 4():164. PubMed ID: 25019059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperactivation of oxidative mitochondrial metabolism in epithelial cancer cells in situ: visualizing the therapeutic effects of metformin in tumor tissue.
    Whitaker-Menezes D; Martinez-Outschoorn UE; Flomenberg N; Birbe RC; Witkiewicz AK; Howell A; Pavlides S; Tsirigos A; Ertel A; Pestell RG; Broda P; Minetti C; Lisanti MP; Sotgia F
    Cell Cycle; 2011 Dec; 10(23):4047-64. PubMed ID: 22134189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The α-tocopherol derivative ESeroS-GS induces cell death and inhibits cell motility of breast cancer cells through the regulation of energy metabolism.
    Zhao L; Zhao X; Zhao K; Wei P; Fang Y; Zhang F; Zhang B; Ogata K; Mori A; Wei T
    Eur J Pharmacol; 2014 Dec; 745():98-107. PubMed ID: 25446928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The mammary gland: a tissue sensitive to environmental exposures.
    Fenton SE
    Rev Environ Health; 2009; 24(4):319-25. PubMed ID: 20384040
    [No Abstract]   [Full Text] [Related]  

  • 11. Endocrine disruptors and the breast: early life effects and later life disease.
    Macon MB; Fenton SE
    J Mammary Gland Biol Neoplasia; 2013 Mar; 18(1):43-61. PubMed ID: 23417729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preface: prolactin and growth hormone in mammary gland development and breast cancer.
    J Mammary Gland Biol Neoplasia; 2008 Mar; 13(1):1. PubMed ID: 18236141
    [No Abstract]   [Full Text] [Related]  

  • 13. Environmental exposures and mammary gland development: state of the science, public health implications, and research recommendations.
    Rudel RA; Fenton SE; Ackerman JM; Euling SY; Makris SL
    Environ Health Perspect; 2011 Aug; 119(8):1053-61. PubMed ID: 21697028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondrial OXPHOS Induced by RB1 Deficiency in Breast Cancer: Implications for Anabolic Metabolism, Stemness, and Metastasis.
    Zacksenhaus E; Shrestha M; Liu JC; Vorobieva I; Chung PED; Ju Y; Nir U; Jiang Z
    Trends Cancer; 2017 Nov; 3(11):768-779. PubMed ID: 29120753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progesterone regulation of stem and progenitor cells in normal and malignant breast.
    Axlund SD; Sartorius CA
    Mol Cell Endocrinol; 2012 Jun; 357(1-2):71-9. PubMed ID: 21945473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondrial biogenesis: pharmacological approaches.
    Valero T
    Curr Pharm Des; 2014; 20(35):5507-9. PubMed ID: 24606795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nutritional modulation of terminal end buds: its relevance to breast cancer prevention.
    Hilakivi-Clarke L
    Curr Cancer Drug Targets; 2007 Aug; 7(5):465-74. PubMed ID: 17691906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exposures to synthetic estrogens at different times during the life, and their effect on breast cancer risk.
    Hilakivi-Clarke L; de Assis S; Warri A
    J Mammary Gland Biol Neoplasia; 2013 Mar; 18(1):25-42. PubMed ID: 23392570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NLRX1 regulates TNF-α-induced mitochondria-lysosomal crosstalk to maintain the invasive and metastatic potential of breast cancer cells.
    Singh K; Roy M; Prajapati P; Lipatova A; Sripada L; Gohel D; Singh A; Mane M; Godbole MM; Chumakov PM; Singh R
    Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1460-1476. PubMed ID: 30802640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered carcinogenesis and proteome in mammary glands of rats after prepubertal exposures to the hormonally active chemicals bisphenol a and genistein.
    Betancourt AM; Wang J; Jenkins S; Mobley J; Russo J; Lamartiniere CA
    J Nutr; 2012 Jul; 142(7):1382S-8S. PubMed ID: 22649256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.